Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1769, Issue 11-12, 2007, Pages 603-612

  Kim, Kihoon ^a   Liu, Fenyong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense; External guide sequence; Gene targeting; Gene therapy; Ribozyme; RNase P

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; MESSENGER RNA; RIBONUCLEASE P; RIBOZYME; RNA;

ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA PROCESSING;

BASE SEQUENCE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TECHNIQUES; HUMANS; MODELS, GENETIC; RIBONUCLEASE P; RNA INTERFERENCE; RNA, CATALYTIC;

ESCHERICHIA COLI;

EID: 36048970169     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2007.09.001     Document Type: Review

References (87)

1. Scherer L.J., and Rossi J.J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21 (2003) 1457-1465
2. Stein C.A., and Cheng Y.C. Antisense oligonucleotides as therapeutic agents-is the bullet really magical?. Science 261 (1993) 1004-1012
3. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., and Altman S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35 (1983) 849-857
4. Kruger K., Grabowski P.J., Zaug A.J., Sands J., Gottschling D.E., and Cech T.R. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31 (1982) 147-157
5. Doudna J.A., and Cech T.R. The chemical repertoire of natural ribozymes. Nature 418 (2002) 222-228
6. Gopalan V., Vioque A., and Altman S. RNase P: variations and uses. J. Biol. Chem. 277 (2002) 6759-6762
7. Robertson H.D., Altman S., and Smith J.D. Purification and properties of a specific Escherichia coli ribonuclease which cleaves a tyrosine transfer ribonucleic acid precursor. J. Biol. Chem. 247 (1972) 5243-5251
8. Altman S., and Kirsebom L. In: Gesteland R., Cech T., and Atkins J. (Eds). The RNA World (1999), Cold Spring Harbor Laboratory Press 351-380
9. Frank D.N., and Pace N.R. Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Ann. Rev. Biochem. 67 (1998) 153-180
10. Xiao S., Scott F., Fierke C.A., and Engelke D.R. Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes. Ann. Rev. Biochem. 71 (2002) 165-189
11. Komine Y., Kitabatake M., Yokogawa T., Nishikawa K., and Inokuchi H. A tRNA-like structure is present in 10Sa RNA, a small stable RNA from Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9223-9227
12. Li Y., and Altman S. Polarity effects in the lactose operon of Escherichia coli. J. Mol. Biol. 339 (2004) 31-39
13. Alifano P., Rivellini F., Piscitelli C., Arraiano C.M., Bruni C.B., and Carlomagno M.S. Ribonuclease E provides substrates for ribonuclease P-dependent processing of a polycistronic mRNA. Genes Dev. 8 (1994) 3021-3031
14. Altman S., Wesolowski D., Guerrier-Takada C., and Li Y. RNase P cleaves transient structures in some riboswitches. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11284-11289
15. Hartmann R.K., Heinrich J., Schlegl J., and Schuster H. Precursor of C4 antisense RNA of bacteriophages P1 and P7 is a substrate for RNase P of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5822-5826
16. Peck-Miller K.A., and Altman S. Kinetics of the processing of the precursor to 4.5 S RNA, a naturally occurring substrate for RNase P from Escherichia coli. J. Mol. Biol. 221 (1991) 1-5
17. Reiner R., Ben-Asouli Y., Krilovetzky I., and Jarrous N. A role for the catalytic ribonucleoprotein RNase P in RNA polymerase III transcription. Genes Dev. 20 (2006) 1621-1635
18. Hartmann E., and Hartmann R.K. The enigma of ribonuclease P evolution. Trends Genet. 19 (2003) 561-569
19. Crary S.M., Niranjanakumari S., and Fierke C.A. The protein component of Bacillus subtilis ribonuclease P increases catalytic efficiency by enhancing interactions with the 5' leader sequence of pre-tRNAAsp. Biochemistry 37 (1998) 9409-9416
20. Gopalan V., Baxevanis A.D., Landsman D., and Altman S. Analysis of the functional role of conserved residues in the protein subunit of ribonuclease P from Escherichia coli. J. Mol. Biol. 267 (1997) 818-829
21. Hsieh J., Andrews A.J., and Fierke C.A. Roles of protein subunits in RNA-protein complexes: lessons from ribonuclease P. Biopolymers 73 (2004) 79-89
22. Kim J.J., Kilani A.F., Zhan X., Altman S., and Liu F. The protein cofactor allows the sequence of an RNase P ribozyme to diversify by maintaining the catalytically active structure of the enzyme. RNA 3 (1997) 613-623
23. Kurz J.C., Niranjanakumari S., and Fierke C.A. Protein component of Bacillus subtilis RNase P specifically enhances the affinity for precursor-tRNAAsp. Biochemistry 37 (1998) 2393-2400
24. Niranjanakumari S., Stams T., Crary S.M., Christianson D.W., and Fierke C.A. Protein component of the ribozyme ribonuclease P alters substrate recognition by directly contacting precursor tRNA. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15212-15217
25. Westhof E., Wesolowski D., and Altman S. Mapping in three dimensions of regions in a catalytic RNA protected from attack by an Fe(II)-EDTA reagent. J. Mol. Biol. 258 (1996) 600-613
26. Kurz J.C., and Fierke C.A. The affinity of magnesium binding sites in the Bacillus subtilis RNase P x pre-tRNA complex is enhanced by the protein subunit. Biochemistry 41 (2002) 9545-9558
27. Jarrous N., Reiner R., Wesolowski D., Mann H., Guerrier-Takada C., and Altman S. Function and subnuclear distribution of Rpp21, a protein subunit of the human ribonucleoprotein ribonuclease P. RNA 7 (2001) 1153-1164
28. Duarte C.M., Wadley L.M., and Pyle A.M. RNA structure comparison, motif search and discovery using a reduced representation of RNA conformational space. Nucleic Acids Res. 31 (2003) 4755-4761
29. Leontis N.B., and Westhof E. Analysis of RNA motifs. Curr. Opin. Struct. Biol. 13 (2003) 300-308
30. Forster A.C., and Altman S. External guide sequences for an RNA enzyme. Science 249 (1990) 783-786
31. McClain W.H., Guerrier-Takada C., and Altman S. Model substrates for an RNA enzyme. Science 238 (1987) 527-530
32. Guerrier-Takada C., Li Y., and Altman S. Artificial regulation of gene expression in Escherichia coli by RNase P. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11115-11119
33. Guerrier-Takada C., Salavati R., and Altman S. Phenotypic conversion of drug-resistant bacteria to drug sensitivity. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 8468-8472
34. Liu F., and Altman S. Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli. Genes Dev. 9 (1995) 471-480
35. McKinney J., Guerrier-Takada C., Wesolowski D., and Altman S. Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6605-6610
36. Yuan Y., Hwang E.S., and Altman S. Targeted cleavage of mRNA by human RNase P. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 8006-8010
37. Werner M., Rosa E., Nordstrom J.L., Goldberg A.R., and George S.T. Short oligonucleotides as external guide sequences for site-specific cleavage of RNA molecules with human RNase P. RNA 4 (1998) 847-855
38. Ma M., Benimetskaya L., Lebedeva I., Dignam J., Takle G., and Stein C.A. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences. Nat. Biotechnol. 18 (2000) 58-61
39. Frank D.N., Harris M.E., and Pace N.R. Rational design of self-cleaving pre-tRNA-ribonuclease P RNA conjugates. Biochemistry 33 (1994) 10800-10808
40. Cobaleda C., and Sanchez-Garcia I. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood 95 (2000) 731-737
41. Trang P., Kilani A., Kim J., and Liu F. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J. Mol. Biol. 301 (2000) 817-826
42. Kazantsev A.V., and Pace N.R. Bacterial RNase P: a new view of an ancient enzyme. Nat. Rev. Microbiol. 4 (2006) 729-740
43. Bertr E.L., and Rossi J.J. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 13 (1994) 2904-2912
44. Zhu J., Trang P., Kim K., Zhou T., Deng H., and Liu F. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9073-9078
45. Zaug A.J., and Cech T.R. Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA. RNA 1 (1995) 363-374
46. Knapp G. Enzymatic approaches to probing of RNA secondary and tertiary structure. Methods Enzymol. 180 (1989) 192-212
47. Trang P., Hsu A.W., and Liu F. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Res. 27 (1999) 4590-4597
48. Mathews D.H., Disney M.D., Childs J.L., Schroeder S.J., Zuker M., and Turner D.H. Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7287-7292
49. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415
50. Lo K.M., Biasolo M.A., Dehni G., Palu G., and Haseltine W.A. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology 190 (1992) 176-183
51. Ojwang J.O., Hampel A., Looney D.J., Wong-Staal F., and Rappaport J. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10802-10806
52. Sarver N., Cantin E.M., Chang P.S., Zaia J.A., Ladne P.A., Stephens D.A., and Rossi J.J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247 (1990) 1222-1225
53. Sun L.Q., Warrilow D., Wang L., Witherington C., Macpherson J., and Symonds G. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9715-9719
54. Sun L.Q., Pyati J., Smythe J., Wang L., Macpherson J., Gerlach W., and Symonds G. Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7272-7276
55. Wang L., Witherington C., King A., Gerlach W.L., Carr A., Penny R., Cooper D., Symonds G., and Sun L.Q. Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum. Gene Ther. 9 (1998) 1283-1291
56. Weerasinghe M., Liem S.E., Asad S., Read S.E., and Joshi S. Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J. Virol. 65 (1991) 5531-5534
57. Liu F., and Altman S. Requirements for cleavage by a modified RNase P of a small model substrate. Nucleic Acids Res. 24 (1996) 2690-2696
58. Yuan Y., and Altman S. Selection of guide sequences that direct efficient cleavage of mRNA by human ribonuclease P. Science 263 (1994) 1269-1273
59. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
60. Joyce G.F. Directed molecular evolution. Sci. Am. 267 (1992) 90-97
61. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
62. Berzal-Herranz A., Joseph S., and Burke J.M. In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions. Genes Dev. 6 (1992) 129-134
63. Joseph S., and Burke J.M. Optimization of an anti-HIV hairpin ribozyme by in vitro selection. J. Biol. Chem. 268 (1993) 24515-24518
64. Lorsch J.R., and Szostak J.W. In vitro evolution of new ribozymes with polynucleotide kinase activity. Nature 371 (1994) 31-36
65. Kilani A.F., Trang P., Jo S., Hsu A., Kim J., Nepomuceno E., Liou K., and Liu F. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J. Biol. Chem. 275 (2000) 10611-10622
66. Chen J.L., Nolan J.M., Harris M.E., and Pace N.R. Comparative photocross-linking analysis of the tertiary structures of Escherichia coli and Bacillus subtilis RNase P RNAs. EMBO J. 17 (1998) 1515-1525
67. Haas E.S., Brown J.W., Pitulle C., and Pace N.R. Further perspective on the catalytic core and secondary structure of ribonuclease P RNA. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 2527-2531
68. Massire C., Jaeger L., and Westhof E. Derivation of the three-dimensional architecture of bacterial ribonuclease P RNAs from comparative sequence analysis. J. Mol. Biol. 279 (1998) 773-793
69. Trang P., Hsu A., Zhou T., Lee J., Kilani A.F., Nepomuceno E., and Liu F. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding. J. Mol. Biol. 315 (2002) 573-586
70. Zou H., Lee J., Kilani A.F., Kim K., Trang P., Kim J., and Liu F. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA. J. Biol. Chem. 279 (2004) 32063-32070
71. McKinney J.S., Zhang H., Kubori T., Galan J.E., and Altman S. Disruption of type III secretion in Salmonella enterica serovar Typhimurium by external guide sequences. Nucleic Acids Res. 32 (2004) 848-854
72. Hnatyszyn H., Spruill G., Young A., Seivright R., and Kraus G. Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Gene Ther. 8 (2001) 1863-1871
73. Kraus G., Geffin R., Spruill G., Young A.K., Seivright R., Cardona D., Burzawa J., and Hnatyszyn H.J. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3406-3411
74. Plehn-Dujowich D., and Altman S. Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7327-7332
75. Zhou T., Kim J., Kilani A.F., Kim K., Dunn W., Jo S., Nepomuceno E., and Liu F. In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression. J. Biol. Chem. 277 (2002) 30112-30120
76. Roizman B., and Knipe D.M. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-William & Wilkins, Philadelphia, Pa. 2399-2460
77. Mocarski E.S., and Courcelle C.T. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-William & Wilkins, Philadelphia, Pa. 2629-2673
78. Moore P.S., and Chang Y. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-William & Wilkins, Philadelphia, Pa. 2803-2834
79. Kim K., Umamoto S., Trang P., Hai R., and Liu F. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus. RNA 10 (2004) 438-447
80. Kim K., and Liu F. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA. Methods Mol. Biol. 252 (2004) 399-412
81. Kawa D., Wang J., Yuan Y., and Liu F. Inhibition of viral gene expression by human ribonuclease P. RNA 4 (1998) 1397-1406
82. Li H., Trang P., Kim K., Zhou T., Umamoto S., and Liu F. Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA. RNA 12 (2006) 63-72
83. Yang Y.H., Li H., Zhou T., Kim K., and Liu F. Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus. Nucleic Acids Res. 34 (2006) 575-583
84. Raj S.M., and Liu F. Engineering of RNase P ribozyme for gene-targeting applications. Gene 313 (2003) 59-69
85. Trang P., Kim K., and Liu F. Developing RNase P ribozymes for gene-targeting and antiviral therapy. Cell. Microbiol. 6 (2004) 499-508
86. Yu X., Trang P., Shah S., Atanasov I., Kim Y.H., Bai Y., Zhou Z.H., and Liu F. Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7103-7108
87. Verma S., and Eckstein F. Modified oligonucleotides: synthesis and strategy for users. Ann. Rev. Biochem. 67 (1998) 99-134